Orilissa 150 mg/1
Elagolix · TABLET, FILM COATED · AbbVie Inc.
No Recall History
Plain English
Orilissa is a tablet, film coated containing elagolix at 150 mg/1, taken oral. Manufactured by AbbVie Inc..
Key Facts
- Brand Name
- Orilissa
- Generic Name
- Elagolix
- NDC Code (Product)
0074-0038- Manufacturer
- AbbVie Inc.
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA210450
- Marketing Start
- 07/23/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Orilissa used for?
Orilissa contains Elagolix. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Orilissa a controlled substance?
Orilissa is not classified as a controlled substance by the DEA.
What is the generic name for Orilissa?
The generic name for Orilissa is Elagolix. There are 1 other brand versions of Elagolix.
What is the NDC code for Orilissa 150 mg/1?
The NDC (National Drug Code) for Orilissa 150 mg/1 is 0074-0038, listed by AbbVie Inc..